national stem-cell therapy logo

Unleashing Cardiac Stem Cells: Transforming Heart Health

illustration of cardiac stem cells

Introduction Let’s dive into the incredible world of cardiac stem cells and their potential to transform the field of heart disease treatment. If you or a loved one are dealing with heart conditions, we understand the challenges you face, and we’re here to offer hope. Heart conditions can have a profound impact on individuals, affecting […]

Exploring the Benefits of MSCT for IHD

Abstract painting representing Ischemic Heart Disease

Introduction Mesenchymal Stem Cell Therapy (MSCT) is a promising, yet still experimental form of treatment that has the potential to revolutionize the management of Ischemic Heart Disease (IHD). What are Mesenchymal Stem Cells Mesenchymal stem cells (MSCs) are a type of adult stem cell found in the body that can differentiate into several different types […]

BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

BioCardia Logo

SUNNYVALE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP® Cell Therapy Heart Failure Trial (clinicaltrials.gov Identifier: […]

Stem cells saving lives from heart birth defects

Stem cell therapy for heart birth defects

Stems Cells are being used to help revitalize the hearts of babies who suffer from a severe heart defect and sometimes prevent the need for a transplant. Video Transcript: Almost 1 out of 100 babies is born with a heart defect. Each year in the U.S. many of these babies will need surgery within weeks […]

Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product

Creative Medical Technology Holdings

PHOENIX, April 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced progress in developing a reproducible clinical grade product of ImmCelz®. Multiple clinical experiments were performed in which […]